Indivior Pharmaceuticals, Inc. INDV Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Indivior Pharmaceuticals, Inc. ’s reported figures.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's free cash flow?
- Indivior Pharmaceuticals, Inc. (INDV) reported free cash flow of -$29M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's free cash flow changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's free cash flow decreased by 141.4% year-over-year, from $70M to -$29M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's free cash flow?
- Over 2 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's free cash flow has grown at a 221.5% compound annual growth rate (CAGR), from -$9M to -$93M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.